Psychemedics Performance
The company holds a Beta of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and Psychemedics are completely uncorrelated.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Psychemedics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound primary indicators, Psychemedics is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
Begin Period Cash Flow | 4.8 M |
Psychemedics |
Psychemedics Relative Risk vs. Return Landscape
If you would invest (100.00) in Psychemedics on December 20, 2024 and sell it today you would earn a total of 100.00 from holding Psychemedics or generate -100.0% return on investment over 90 days. Psychemedics is generating negative expected returns assuming volatility of 0.0% on return distribution over 90 days investment horizon. In other words, 0% of pink sheets are less volatile than Psychemedics, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
Risk |
Psychemedics Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Psychemedics' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Psychemedics, and traders can use it to determine the average amount a Psychemedics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
PMD |
Based on monthly moving average Psychemedics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Psychemedics by adding Psychemedics to a well-diversified portfolio.
Psychemedics Fundamentals Growth
Psychemedics Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Psychemedics, and Psychemedics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Psychemedics Pink Sheet performance.
Return On Equity | -0.61 | |||
Return On Asset | -0.16 | |||
Profit Margin | (0.22) % | |||
Operating Margin | (0.19) % | |||
Current Valuation | 14.22 M | |||
Shares Outstanding | 5.89 M | |||
Price To Earning | 92.08 X | |||
Price To Book | 2.58 X | |||
Price To Sales | 0.76 X | |||
Revenue | 22.1 M | |||
EBITDA | (251 K) | |||
Cash And Equivalents | 1.79 M | |||
Cash Per Share | 0.32 X | |||
Total Debt | 2.3 M | |||
Debt To Equity | 0.36 % | |||
Book Value Per Share | 1.15 X | |||
Cash Flow From Operations | (1.48 M) | |||
Earnings Per Share | (0.51) X | |||
Total Asset | 12.33 M | |||
Retained Earnings | (16.77 M) | |||
Current Asset | 8.46 M | |||
Current Liabilities | 3.56 M | |||
Things to note about Psychemedics performance evaluation
Checking the ongoing alerts about Psychemedics for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Psychemedics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Psychemedics is not yet fully synchronised with the market data | |
Psychemedics has some characteristics of a very speculative penny stock | |
Psychemedics has a very high chance of going through financial distress in the upcoming years | |
The company reported the last year's revenue of 22.1 M. Reported Net Loss for the year was (4.15 M) with profit before taxes, overhead, and interest of 9.29 M. | |
Psychemedics has about 1.79 M in cash with (1.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.32. | |
Roughly 23.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Psychemedics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Psychemedics' stock is overvalued or undervalued compared to its peers.
- Examining Psychemedics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Psychemedics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Psychemedics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Psychemedics' pink sheet. These opinions can provide insight into Psychemedics' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Consideration for investing in Psychemedics Pink Sheet
If you are still planning to invest in Psychemedics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Psychemedics' history and understand the potential risks before investing.
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Stocks Directory Find actively traded stocks across global markets | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |